• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[科赫氏杆菌原发性耐药现象:关于1972年至1975年在都灵圣路易吉肺病医院收集病例的报告]

[Phenomenon of primary resistance of Koch's bacillus: report on cases assembled at the pneumological hospital S. Luigi in Turin from 1972 to 1975].

作者信息

Briccarello L, Bardessono F, Daglio C, Ferraro U, Giorgis G E, Moschini M T

出版信息

G Batteriol Virol Immunol. 1976 Jan-Jun;69(1-6):49-59.

PMID:828885
Abstract

In this work the authors stress the importance reached in recent years by the primary resistance phenomenon in pulmonary consumption, and they explain the results pointed out by the examination of 171 antibiograms effected from 1972 to 1975 on patients with pathological forms ascertained for the first time. They conclude by underlining the reduction of the primary resistance when employing common antibiotics and, on the contrary, its rise with the use of the rifampicin which has recently been introduced in therapy; lastly they put into evidence the epidemiological importance of the phenomenon itself.

摘要

在这项研究中,作者强调了近年来原发性耐药现象在肺结核中所达到的重要性,并解释了对1972年至1975年首次确诊为病理类型的患者进行的171份抗菌谱检查所指出的结果。他们通过强调使用普通抗生素时原发性耐药性的降低来得出结论,相反,随着最近在治疗中引入的利福平的使用,原发性耐药性会上升;最后,他们揭示了该现象本身在流行病学上的重要性。

相似文献

1
[Phenomenon of primary resistance of Koch's bacillus: report on cases assembled at the pneumological hospital S. Luigi in Turin from 1972 to 1975].[科赫氏杆菌原发性耐药现象:关于1972年至1975年在都灵圣路易吉肺病医院收集病例的报告]
G Batteriol Virol Immunol. 1976 Jan-Jun;69(1-6):49-59.
2
[Drug resistance of Mycobacterium tuberculosis. Behavior of the phenomenon during the past 10 years].
Ann Ist Carlo Forlanini. 1969;29(4):286-300.
3
[The current epidemiologic profile of the drug resistance of Koch's bacillus to antitubercular antibiotic chemicals].[结核杆菌对抗结核化学抗生素的耐药性当前流行病学概况]
Minerva Med. 1990 Jul-Aug;81(7-8):547-53.
4
Drug resistance to the first line of antitubercular regimen (a preliminary report).对一线抗结核治疗方案的耐药性(初步报告)。
Indian J Public Health. 1998 Oct-Dec;42(4):126-30.
5
[Current aspects of drug resistance of the Koch bacillus in the area of one district].[某地区结核杆菌耐药性的当前情况]
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1981 Oct-Dec;30(4):213-8.
6
[The phenomenon of primary mycobacterial resistance in the records of the Clinica Tisiologica di Parma].
Arch Monaldi. 1972 Jul-Aug;27(4):495-500.
7
[Drug resistance of Koch's mycobacterium in patients with initially detected pulmonary tuberculosis].初诊肺结核患者中结核分枝杆菌的耐药性
Vrach Delo. 1968 Sep;9:84-5.
8
[Drug resistance of Mycobacterium tuberculosis and its significance in the hospital practice].[结核分枝杆菌的耐药性及其在医院实践中的意义]
Probl Tuberk. 1996(3):6-8.
9
[The incidence of primary mycobacterial resistance in the records of the Clinica Tisiologica di Catania].[卡塔尼亚组织病理学诊所记录中的原发性分枝杆菌耐药率]
Arch Monaldi. 1972 Jul-Aug;27(4):501-5.
10
[The influence of the resistance of Koch's bacillus to antibiotics on the mode of treatment of tuberculosis].[结核杆菌对抗生素的耐药性对结核病治疗方式的影响]
Prod Probl Pharm. 1965 Apr;20(4):192-6.

引用本文的文献

1
Evidence that rifampicin can be used safely for non-tuberculous diseases.利福平可安全用于非结核疾病的证据。
Thorax. 1980 Oct;35(10):788-91. doi: 10.1136/thx.35.10.788.